NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 51 filers reported holding NEUBASE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $79 | -2.5% | 427 | 0.0% | 0.00% | – |
Q4 2022 | $81 | – | 427 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 427 | 0.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 427 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 427 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | -50.0% | 427 | 0.0% | 0.00% | – |
Q3 2021 | $2,000 | 0.0% | 427 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | – | 427 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CARNEGIE MELLON UNIVERSITY | 939,412 | $371,000 | 0.21% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $186,000 | 0.20% |
CM Management, LLC | 450,000 | $178,000 | 0.20% |
Decheng Capital Management III (Cayman), LLC | 1,000,000 | $395,000 | 0.14% |
AIGH Capital Management LLC | 872,023 | $345,000 | 0.11% |
Greenlight Capital | 2,727,027 | $1,077,000 | 0.08% |
Worth Venture Partners, LLC | 212,035 | $84,000 | 0.05% |
PERKINS CAPITAL MANAGEMENT INC | 98,000 | $39,000 | 0.04% |
Sio Capital Management, LLC | 259,441 | $102,000 | 0.03% |
PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $123,000 | 0.00% |